Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Jamy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Tennessee (Nashville)Residency, Internal Medicine, 2013 - 2016
Aga Khan Medical CollegeClass of 2012
Certifications & Licensure
AL State Medical License 2016 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia Start of enrollment: 2022 Jun 01
Roles: Contact
- Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study Start of enrollment: 2024 May 02
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Olverembatinib in chronic myeloid leukemia-Review of historical development, current status, and future research.Hagop Kantarjian, Yifan Zhai, Vivian G Oehler, Omer Jamy, Paul B Koller
Cancer. 2025-04-15 - Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-03-10 - Revisiting the Role of Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia.Omer Jamy, Garrett Bourne, Todd William Mudd, Haley Thigpen, Ravi Bhatia
Cancers. 2025-03-06
Abstracts/Posters
- Genomic Landscape of Sex Disparities in Multiple MyelomaOmer Jamy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine...ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
SELLAS Life Sciences to Host Virtual Expert Panel Discussion on GFH009 in Acute Myeloid LeukemiaMay 16th, 2023- SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia ProgramJanuary 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
